KATHERIN RODRIGUEZ: Open Payments
NPI 1851921738 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 74 payments from 16 companies in 2025. Trend: 2023 $250 · 2024 $1,686 · 2025 $2,205
Food & beverage: $2,205
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 6 | $329 |
| Incyte Corporation | 8 | $289 |
| GENZYME CORPORATION | 7 | $262 |
| AstraZeneca Pharmaceuticals LP | 10 | $237 |
| Pharmacosmos Therapeutics Inc. | 9 | $190 |
| Novartis Pharmaceuticals Corporation | 9 | $186 |
| SOBI, INC | 7 | $175 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| Eisai Inc. | 4 | $85 |
| Apellis Pharmaceuticals, Inc. | 3 | $81 |
Products named: BESREMI, ENHERTU, JAKAFI, MONOFERRIC, Doptelet, AYVAKIT, Fabhalta, Lenvima.
Industry payments across FL — which companies pay providers there.
